Twinpig Biolab, Inc.

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Mar 1, 2026TrialClinical Trial of TB511 in Advanced Solid Tumors

Jul 29, 2016FDAPrinivil — QBRELIS

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

1 patent group across drugs · Source: FDA Orange Book

DrugExpires

Prinivil12 patentsNov 6, 2035

Regulatory

Regulatory Timeline

19891 event

FDASep 13

Tenormin — TENORMIN

Application NDA019058 (NDA)

19901 event

FDAApr 9

Tenormin — TENORMIN

Application NDA018240 (NDA)

19931 event

FDAApr 29

Prinivil — ZESTRIL

Application NDA019777 (NDA)

19941 event

FDAJan 28

Prinivil — PRINIVIL

Application NDA019558 (NDA)

20161 event

FDAJul 29

Prinivil — QBRELIS

Application NDA208401 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)